- Excellent financial health (Piotroski 8/9)
- High gross margin of 69.0%
- Attractive free cash flow ratio of 7.9x
OptimizeRx Corporation stock price ended at $6.05 on Friday, after losing 3.51%
(Updated on Jul 31, 2026)
The OptimizeRx Corporation stock price fell by -3.51% on the last day (Friday, 31st Jul 2026) from $6.27 to $6.05. During the last trading day the stock fluctuated 9.27% from a day low at $5.72 to a day high of $6.25. The price has fallen in 6 of the last 10 days and is down by -9.57% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -55 thousand shares and in total, 274 thousand shares were bought and sold for approximately $1.66 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.97% during the next 3 months and, with a 90% probability hold a price between $5.75 and $7.94 at the end of this 3-month period.
OPRX Signals & Forecast
The OptimizeRx Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.27. On a fall, the stock will find some support from the long-term average at approximately $5.90. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 17, 2026, and so far it has fallen -9.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for OptimizeRx Corporation stock
On the downside, the stock finds support just below today's level from accumulated volume at $5.12 and $4.92. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, OptimizeRx Corporation finds support just below today's level at $5.12. If this is broken, then the next support from accumulated volume will be at $4.92 and $4.83.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.530 between high and low, or 9.27%. For the last week, the stock has had daily average volatility of 5.01%.
Our recommended stop-loss: $5.67 (-6.23%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)
Trading Expectations (OPRX) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect OptimizeRx Corporation to open at $6.01, and during the day (based on 14 day Average True Range), to move between $5.90 and $6.20, which gives a possible trading interval of +/-$0.301 (+/-5.10%) up or down from last closing price. If OptimizeRx Corporation takes out the full calculated possible swing range there will be an estimated 5.10% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $6.08 (0.50%) than the support at $5.12 (15.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
OptimizeRx Corporation will release earnings AMC on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.110. We will update the financials statements for OptimizeRx Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.58% in the first trading day after earnings release.
Is OptimizeRx Corporation stock A Buy?
OptimizeRx Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.365
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $6.01 ( 0.716%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
OPRX Performance
Trading levels for OPRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.54 | 8.04% |
| R2 | 6.33 | 4.70% |
| R1 | 6.21 | 2.63% |
| Price | 6.05 | |
| S1 | 5.80 | -4.06% |
| S2 | 5.68 | -6.13% |
| S3 | 5.48 | -9.48% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.63 | 9.59% |
| R2 | 6.34 | 4.79% |
| R1 | 6.08 | 0.496% |
| Price | 6.05 | |
| S1 | 5.12 | -15.37% |
| S2 | 4.92 | -18.76% |
| S3 | 4.83 | -20.17% |
FAQ
Click here for our free guide on how to buy OptimizeRx Corporation Stock.
Buy OPRX